CAS RN: 599165-35-2
exo-3-(Boc-aMino)-9-azabi…
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250629
250mg
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 599165-35-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
599165-35-2 / tert-butyl N-(9-azabicyclo[3.3.1]nonan-3-yl)carbamate
Standard CAS: 599165-35-2
Multi CAS: Yes
Basic Information
copy
CAS
599165-35-2 copy
Multi CAS
Yes copy
Molecular Formula
C13H24N2O2 copy
Molecular Weight
240.340000 copy
Exact Mass
240.183778 copy
InChI
InChI=1S/C13H24N2O2/c1-13(2,3)17-12(16)15-11-7-9-5-4-6-10(8-11)14-9/h9-11,14H,4-8H2,1-3H3,(H,15,16)/t9-,10+,11? copy
InChIKey
HWPHWBRCRWNTLX-ZACCUICWSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
17 copy
Fraction Csp3
0.92 copy
Rotatable bonds
1 copy
H-bond acceptors
3 copy
H-bond donors
2 copy
Molar refractivity
66.95 copy
TPSA
50.36 copy
LogP / Solubility
WLOGP
2.18 copy
MLOGP
1.93 copy
XLogP3
2 copy
Consensus LogP
2.04 copy
Log S (ESOL)
-2.64 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-3.11 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.16 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.64 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
4.5 copy